Biopharmaceuticals

Medicinal products derived from biological sources, such as living cells or organisms. Biopharmaceuticals include vaccines, monoclonal antibodies, and gene therapies.

 

Monoclonal Antibodies (mAbs)

Laboratory-produced molecules that can mimic the immune system’s ability to fight off harmful pathogens. They are used in the treatment of various diseases, including cancer and autoimmune disorders.

 

Clinical Trials

Rigorous research studies conducted to evaluate the safety and efficacy of new drugs, treatments, or medical devices in human subjects before they are approved for widespread use.

 

Regenerative Medicine

A field of biopharmaceuticals focused on repairing, replacing, or regenerating damaged tissues or organs using cells, tissues, or biomaterials.

 

Biosimilars

Biological products that are highly similar to an already approved biopharmaceutical, with no clinically meaningful differences. They provide cost-effective alternatives to expensive biologics.

 

Personalized Medicine

Tailoring medical treatment to the individual characteristics of each patient, considering factors like genetics, lifestyle, and environment. This approach aims to maximize treatment effectiveness and minimize side effects.

 

Pharmacovigilance

The science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems.

 

Orphan Drugs

Medications developed to treat rare diseases, often with a limited patient population. Governments may provide incentives to encourage the development of these drugs.

 

Precision Medicine

Similar to personalized medicine, it involves tailoring medical treatment and interventions to the specific characteristics of each patient, with a focus on using genetic information for targeted therapies.

 

Bioinformatics

The application of computational techniques to analyze and interpret biological data, facilitating drug discovery, genomics, and other biopharmaceutical research.

 

Pharmaceutical Manufacturing 

The process of producing pharmaceutical products on a large scale, ensuring consistency, quality, and compliance with regulatory standards.

 

API (Active Pharmaceutical Ingredient)

The biologically active component in a pharmaceutical drug, responsible for its therapeutic effects. It is the substance that produces the intended pharmacological activity.

 

Bioprocessing

The use of biological systems, such as living cells or their components, to produce therapeutic drugs or other valuable products.

 

Drug Delivery Systems

Technologies and methods used to administer pharmaceutical compounds to achieve a therapeutic effect. This includes oral tablets, injections, patches, and other innovative delivery mechanisms.

 

Contract Research Organization (CRO) 

A company that provides research services to the biopharmaceutical and pharmaceutical industries, often assisting in clinical trials, data management, and regulatory affairs.

 

Pharmacokinetics

The study of how the body absorbs, distributes, metabolizes, and excretes drugs over time, influencing the drug’s efficacy and safety.

 

Targeted Therapy

Treatment approaches that specifically target molecules involved in the growth, progression, and spread of cancer cells. It aims to interfere with specific pathways to inhibit the growth of cancer cells while minimizing damage to healthy cells.

 

Health Economics and Outcomes Research (HEOR)

The study of how health care resources are allocated and the outcomes and value associated with various healthcare interventions, including pharmaceuticals.